Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Clinical trial NCT01637961 · COMPLETED
Trial details
- NCT number
- NCT01637961
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-08-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.